H. Tuynman-Qua

930 total citations
18 papers, 694 citations indexed

About

H. Tuynman-Qua is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Pharmacology. According to data from OpenAlex, H. Tuynman-Qua has authored 18 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 6 papers in Cognitive Neuroscience and 4 papers in Pharmacology. Recurrent topics in H. Tuynman-Qua's work include Attention Deficit Hyperactivity Disorder (4 papers), Treatment of Major Depression (3 papers) and Schizophrenia research and treatment (3 papers). H. Tuynman-Qua is often cited by papers focused on Attention Deficit Hyperactivity Disorder (4 papers), Treatment of Major Depression (3 papers) and Schizophrenia research and treatment (3 papers). H. Tuynman-Qua collaborates with scholars based in Netherlands and Switzerland. H. Tuynman-Qua's co-authors include E.Ch. Wolters, Paul Bergmans, Frans de Jonghe, Adriaan Honig, Werner Strik, H. J. J. Wellens, H. M. van Praag, Petra Kuijpers, Richel Lousberg and Emile C. Cheriex and has published in prestigious journals such as Neurology, Journal of Affective Disorders and Psychosomatic Medicine.

In The Last Decade

H. Tuynman-Qua

18 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Tuynman-Qua Netherlands 11 316 179 178 134 118 18 694
Prashant Gajwani United States 13 543 1.7× 135 0.8× 92 0.5× 142 1.1× 144 1.2× 17 956
David Sinyor Canada 9 255 0.8× 118 0.7× 171 1.0× 47 0.4× 84 0.7× 10 878
F. Godemann Germany 15 331 1.0× 112 0.6× 177 1.0× 108 0.8× 34 0.3× 44 927
M. Lunde Denmark 14 234 0.7× 100 0.6× 46 0.3× 224 1.7× 48 0.4× 28 762
Balu Kalayam United States 11 435 1.4× 429 2.4× 131 0.7× 320 2.4× 34 0.3× 23 953
Kay Wilhelm Australia 4 177 0.6× 153 0.9× 54 0.3× 93 0.7× 32 0.3× 4 457
Mary Ann Knesevich United States 9 261 0.8× 65 0.4× 35 0.2× 77 0.6× 96 0.8× 13 576
Daniel F. Maixner United States 13 575 1.8× 272 1.5× 84 0.5× 403 3.0× 107 0.9× 22 1.0k
Jeroen A. van Waarde Netherlands 15 525 1.7× 292 1.6× 111 0.6× 361 2.7× 36 0.3× 60 817
Moshe Kotler Israel 9 148 0.5× 51 0.3× 154 0.9× 74 0.6× 49 0.4× 11 518

Countries citing papers authored by H. Tuynman-Qua

Since Specialization
Citations

This map shows the geographic impact of H. Tuynman-Qua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Tuynman-Qua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Tuynman-Qua more than expected).

Fields of papers citing papers by H. Tuynman-Qua

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Tuynman-Qua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Tuynman-Qua. The network helps show where H. Tuynman-Qua may publish in the future.

Co-authorship network of co-authors of H. Tuynman-Qua

This figure shows the co-authorship network connecting the top 25 collaborators of H. Tuynman-Qua. A scholar is included among the top collaborators of H. Tuynman-Qua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Tuynman-Qua. H. Tuynman-Qua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Troost, Pieter W., Mark‐Peter Steenhuis, H. Tuynman-Qua, et al.. (2006). Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms in Children with Pervasive Developmental Disorders: APilot Study. Journal of Child and Adolescent Psychopharmacology. 16(5). 611–619. 64 indexed citations
2.
Kemner, Chantal, Sophie H. N. Willemsen‐Swinkels, Maretha Jonge, H. Tuynman-Qua, & Hermán van Engeland. (2002). Open-Label Study of Olanzapine in Children with Pervasive Developmental Disorder. Journal of Clinical Psychopharmacology. 22(5). 455–460. 87 indexed citations
3.
Tuynman-Qua, H., et al.. (2001). Relation between of Life and Coping and Social Behaviour in Depression. The European Journal of Psychiatry. 15(1). 49–56. 4 indexed citations
4.
Strik, Werner, Adriaan Honig, Richel Lousberg, et al.. (2000). Efficacy and Safety of Fluoxetine in the Treatment of Patients With Major Depression After First Myocardial Infarction: Findings From a Double-Blind, Placebo-Controlled Trial. Psychosomatic Medicine. 62(6). 783–789. 189 indexed citations
5.
Kemner, Chantal, H. van Engeland, & H. Tuynman-Qua. (2000). An open-label study of olanzapine in children with PDD. Schizophrenia Research. 41(1). 194–194. 8 indexed citations
6.
Hulstijn, Wouter, et al.. (2000). Is olanzapine a substitute for clozapine? The effects on psychomotor performance. Schizophrenia Research. 41(1). 187–187. 11 indexed citations
7.
Sabbe, Bernard, et al.. (1999). Retardation in depression: assessment by means of simple motor tasks. Journal of Affective Disorders. 55(1). 39–44. 72 indexed citations
8.
Kemner, Chantal, H. van Engeland, & H. Tuynman-Qua. (1999). An open-label study of olanzapine in children with Pervasive Development Disorder. European Neuropsychopharmacology. 9. 287–288. 1 indexed citations
9.
Tuynman-Qua, H., et al.. (1998). Subjective experience of patients on olanzapine in comparison to other antipsychotics. European Psychiatry. 13(S4). 310s–310s. 1 indexed citations
10.
Tuynman-Qua, H., et al.. (1998). Subjective experience of patients on olanzapine in comparison to other antipsychotics. European Neuropsychopharmacology. 8. S247–S247. 1 indexed citations
11.
Tuynman-Qua, H., et al.. (1998). Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease. Neurology. 50(4). 1196–1196. 7 indexed citations
12.
Tuynman-Qua, H., Frans de Jonghe, & Stephen P. McKenna. (1997). Quality of life in depression scale (QLDS). Development, reliability, validity, responsiveness and application. European Psychiatry. 12(4). 199–202. 26 indexed citations
13.
Wolters, E.Ch., et al.. (1996). Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease. Neurology. 47(4). 1085–1087. 127 indexed citations
14.
Brandenburg, Simone, et al.. (1993). Treatment of premenstrual syndrome with fluoxetine. International Clinical Psychopharmacology. 8(4). 315–318. 20 indexed citations
15.
Tuynman-Qua, H., et al.. (1992). A SCALE FOR THE QUALITY OF LIFE IN DEPRESSION (QLDS): DEVELOPMENT AND FIRST RESULTS. Clinical Neuropharmacology. 15. 155B–155B. 7 indexed citations
16.
Jonghe, Frans de, et al.. (1991). A Randomized, Double-Blind Study of Fluoxetine and Maprotiline in the Treatment of Major Depression. Pharmacopsychiatry. 24(2). 62–67. 27 indexed citations
17.
Jonghe, Frans de, J. A. Swinkels, & H. Tuynman-Qua. (1991). Randomized Double-Blind Study of Fluvoxamine and Maprotiline in Treatment of Depression. Pharmacopsychiatry. 24(1). 21–27. 27 indexed citations
18.
Jonghe, Frans de, et al.. (1989). A Comparative Study of Suriclone, Lorazepam and Placebo in Anxiety Disorder. Pharmacopsychiatry. 22(6). 266–271. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prashant Gajwani Breakdown of academic impact, for papers by David Sinyor Breakdown of academic impact, for papers by F. Godemann Breakdown of academic impact, for papers by M. Lunde Breakdown of academic impact, for papers by Balu Kalayam Breakdown of academic impact, for papers by Kay Wilhelm Breakdown of academic impact, for papers by Mary Ann Knesevich Breakdown of academic impact, for papers by Daniel F. Maixner Breakdown of academic impact, for papers by Jeroen A. van Waarde Breakdown of academic impact, for papers by Moshe Kotler
Rankless by CCL
2026